NYSE:EVMN | Cash Flow Statement | Evommune, Inc.

Complete source-backed cash-flow history.

Available history
2024-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$32.25M$200,000.00
2026-03-31-$21.67M$100,000.00-$27.5M$83,000.00-$85.36M$117.11M
2025-12-31-$28.27M-$16.7M$104,000.00-$122.9M$156.85M
2025-09-30-$12.48M
2025-06-30-$13.57M$200,000.00
2025-03-31-$14.56M$200,000.00-$23.9M$0.00$13.5M-$152,000.00
2024-12-31-$20.73M-$18.51M$0.00-$33.08M$49.7M
2024-09-30-$15.92M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$68.87M$600,000.00-$76.44M$235,000.00-$115.31M$220.76M
2024-12-31-$66.81M$500,000.00-$58.2M$88,000.00-$3.99M$49.42M